Placebo
NBI-98854-DCP3018
Phase 3 small_molecule completed
Quick answer
Placebo for Dyskinesia is a Phase 3 program (small_molecule) at NEUROCRINE BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEUROCRINE BIOSCIENCES INC
- Indication
- Dyskinesia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed